$97.08
0.030.03%
Pre-Market: 4:35 AM EDT
Comments
Loading...
BioNTech Stock Guidance | NASDAQ:BNTX | Benzinga
BioNTech issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/10/2025 | BNTX | BioNTech | FY | 2025 | — | — | — | $1.81B | $2.35B | $2.53B | Get Alert |
| 11/04/2024 | BNTX | BioNTech | FY | 2024 | — | — | — | $2.75B | $2.75B | $2.64B | Get Alert |
| 08/05/2024 | BNTX | BioNTech | FY | 2024 | — | — | — | $2.69B | $3.34B | $3.01B | Get Alert |
| 05/06/2024 | BNTX | BioNTech | FY | 2024 | — | — | — | $2.71B | $3.37B | $3.02B | Get Alert |
| 03/20/2024 | BNTX | BioNTech | FY | 2024 | — | — | — | $2.69B | $3.34B | $3.44B | Get Alert |
| 01/09/2024 | BNTX | BioNTech | FY | 2024 | — | — | — | $3.23B | $3.23B | $4.17B | Get Alert |
FAQ
What is the most recent guidance for BioNTech (BNTX)?
There have been no specific sales or earnings guidance reported for BioNTech in recent months.
Browse guidance and forecast on all stocks.